184 related articles for article (PubMed ID: 26497961)
1. Circadian variation of variability and irregularity of heart rate in patients with permanent atrial fibrillation: relation to symptoms and rate control drugs.
Corino VD; Platonov PG; Enger S; Tveit A; Ulimoen SR
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(12):H2152-7. PubMed ID: 26497961
[TBL] [Abstract][Full Text] [Related]
2. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
[TBL] [Abstract][Full Text] [Related]
3. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.
Ulimoen SR; Enger S; Carlson J; Platonov PG; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Am J Cardiol; 2013 Jan; 111(2):225-30. PubMed ID: 23111138
[TBL] [Abstract][Full Text] [Related]
4. Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.
Corino VD; Holmqvist F; Mainardi LT; Platonov PG
Europace; 2014 Apr; 16(4):587-94. PubMed ID: 23989533
[TBL] [Abstract][Full Text] [Related]
5. Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.
Horjen AW; Ulimoen SR; Enger S; Norseth J; Seljeflot I; Arnesen H; Tveit A
BMC Cardiovasc Disord; 2016 May; 16():79. PubMed ID: 27142292
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
Blagova OV; Nedostup AV
Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
[TBL] [Abstract][Full Text] [Related]
7. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.
Farshi R; Kistner D; Sarma JS; Longmate JA; Singh BN
J Am Coll Cardiol; 1999 Feb; 33(2):304-10. PubMed ID: 9973007
[TBL] [Abstract][Full Text] [Related]
8. Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study.
Inoue H; Atarashi H; Okumura K; Yamashita T; Fukuzawa M; Shiosakai K; Kimura T
J Cardiol; 2017 Jan; 69(1):293-301. PubMed ID: 27364549
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological control of rate and maintenance of sinus rhythm.
Ezekowitz MD; Lampert R
J Thromb Thrombolysis; 1999 Jan; 7(1):33-8. PubMed ID: 10337358
[No Abstract] [Full Text] [Related]
10. Non-invasive assessment of the effect of beta blockers and calcium channel blockers on the AV node during permanent atrial fibrillation.
Sandberg F; Corino VD; Mainardi LT; Ulimoen SR; Enger S; Tveit A; Platonov PG; Sörnmo L
J Electrocardiol; 2015; 48(5):861-6. PubMed ID: 26275982
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Heart Rate Control in Atrial Fibrillation Patients With Obstructive Sleep Apnea.
Konecny T; Brady PA; Park JY; Reddy PK; Ruzek L; Mach L; Caples SM; Somers VK
Am J Cardiol; 2018 Nov; 122(9):1482-1488. PubMed ID: 30244846
[TBL] [Abstract][Full Text] [Related]
12. Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation.
Tse HF; Lam YM; Lau CP; Cheung BM; Kumana CR
Clin Exp Pharmacol Physiol; 2001; 28(5-6):446-50. PubMed ID: 11380520
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
Tuininga YS; Crijns HJ; Brouwer J; van den Berg MP; Man in't Veld AJ; Mulder G; Lie KI
Circulation; 1995 Dec; 92(12):3415-23. PubMed ID: 8521562
[TBL] [Abstract][Full Text] [Related]
14. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
[TBL] [Abstract][Full Text] [Related]
15. Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil.
Botto GL; Bonini W; Broffoni T
Clin Cardiol; 1998 Nov; 21(11):837-40. PubMed ID: 9825197
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic control of heart rate in atrial fibrillation.
Falk RH
Cardiol Clin; 1996 Nov; 14(4):521-36. PubMed ID: 8950054
[TBL] [Abstract][Full Text] [Related]
17. Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers.
Koldenhof T; Van Gelder IC; Crijns HJ; Rienstra M; Tieleman RG
Heart; 2023 Nov; 109(23):1759-1764. PubMed ID: 37433659
[TBL] [Abstract][Full Text] [Related]
18. The influence of antihypertensive agents on circadian rhythms of blood pressure and heart rate in patients with essential hypertension.
Munakata M; Imai Y; Hashimoto J; Sakuma H; Sekino H; Abe K; Yoshinaga K
Tohoku J Exp Med; 1992 Feb; 166(2):217-27. PubMed ID: 1348880
[TBL] [Abstract][Full Text] [Related]
19. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
Chávez LL
Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
Lévy S
Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
